iShares Biotechnology ETF $IBB Shares Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC grew its position in iShares Biotechnology ETF (NASDAQ:IBB) by 5.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 652,818 shares of the financial services provider’s stock after buying an additional 33,268 shares during the quarter. Janney Montgomery Scott LLC owned 1.33% of iShares Biotechnology ETF worth $110,228,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Basepoint Wealth LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $26,000. Cary Street Partners Financial LLC purchased a new position in iShares Biotechnology ETF during the 4th quarter valued at about $29,000. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the second quarter worth about $25,000. Caitlin John LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter worth about $34,000. Finally, Cornerstone Planning Group LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $35,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 2.0%

Shares of NASDAQ IBB opened at $187.38 on Friday. The firm’s 50-day moving average is $171.45 and its two-hundred day moving average is $171.03. iShares Biotechnology ETF has a 12-month low of $125.70 and a 12-month high of $188.69.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were given a dividend of $0.0238 per share. This represents a $0.10 annualized dividend and a dividend yield of 0.1%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.